English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Patent

Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives

MPS-Authors
/persons/resource/persons121504

Kopetzki,  Daniel
Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121636

McQuade,  D. Tyler
Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons121849

Seeberger,  Peter H.
Peter H. Seeberger - Automated Systems, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

/persons/resource/persons127138

Gilmore,  Kerry
Kerry Gilmore, Biomolekulare Systeme, Max Planck Institute of Colloids and Interfaces, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

2156634.pdf
(Publisher version), 968KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Kopetzki, D., McQuade, D. T., Seeberger, P. H., & Gilmore, K.(2015). Method and apparatus for the synthesis of dihydroartemisinin and artemisinin derivatives.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0027-120E-C
Abstract
The present invention is directed to a method for continuous production of dihydroartemisinin and also artemisinin derivatives derived from dihydroartemisinin by using artemisinin or dihydroartemisinic acid (DHAA) as starting material as well as to a continuous flow reactor for producing dihydroartemisinin as well as the artemisinin derivatives. It was found that the reduction of artemisinin to dihydroartemisinin in a continuous process requires a special kind of reactor and a special combination of reagents comprising a hydride reducing agent, at least one activator such as an inorganic activator, at least one solid base, at least one aprotic solvent and at least one C1-C5 alcohol.